RNA INTERFERENCE MEDIATED INHIBITION OF PLATELET DERIVED GROWTH FACTOR (PDGF) AND PLATELET DERIVED GROWTH FACTOR RECEPTOR (PDGFR) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)

Details for Australian Patent Application No. 2003219712 (hide)

Owner RIBOZYME PHARMACEUTICALS, INC.

Inventors MCSWIGGEN, James; BEIGELMAN, Leonid; CHOWRIRA, Bharat

Pub. Number AU-A-2003219712

PCT Number PCT/US03/03473

PCT Pub. Number WO2003/072704

Priority 60/440,129 15.01.03 US; 60/358,580 20.02.02 US; 60/363,124 11.03.02 US; 60/386,782 06.06.02 US; 60/406,784 29.08.02 US; 60/408,378 05.09.02 US; 60/409,293 09.09.02 US

Filing date 5 February 2003

Wipo publication date 9 September 2003

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/440,129 15.01.03 US; 60/358,580 20.02.02 US; 60/363,124 11.03.02 US; 60/386,782 06.06.02 US; 60/406,784 29.08.02 US; 60/408,378 05.09.02 US; 60/409,293 09.09.02 US

16 October 2003 Application Open to Public Inspection

  Published as AU-A-2003219712

18 November 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219713-PRIMARY RAT HEPATOCYTE TOXICITY MODELING

2003219711-FLOW-INDEPENDENT PARAMETER ESTIMATION BASED ON TIDAL BREATHING EXHALATION PROFILES